Phibro Animal Health Corporation (PAHC)

NASDAQ: PAHC · Real-Time Price · USD

34.56

+0.11 (0.32%)

At close: Sep 18, 2026, 4:00 PM EDT

34.56

0.00 (0.01%)

After-hours: Sep 18, 2026, 7:30 PM EDT

Phibro Animal Health Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 18, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Capitalization	1,403	1,274	1,035	679	555	775
Market Cap Growth	-10.27%	23.04%	52.41%	22.41%	-28.38%	-33.76%
Enterprise Value	2,115	1,984	1,730	1,091	983	1,135
Last Close Price	34.56	31.30	25.14	16.17	12.74	17.18

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 18, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
PE Ratio	14.22	12.77	21.45	281.15	17.02	15.76
Forward PE	9.87	9.73	10.58	14.49	10.22	14.49
PS Ratio	0.92	0.84	0.80	0.67	0.57	0.82
PB Ratio	3.64	3.30	3.62	2.65	1.96	2.95
P/TBV Ratio	4.75	4.31	5.46	4.33	3.19	5.33
P/FCF Ratio	142.22	129.10	24.75	14.65	-	-
P/OCF Ratio	20.35	18.47	12.92	7.75	41.69	24.48
PEG Ratio	1.00	0.46	0.52	4.26	1.67	1.67

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 18, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
EV/Sales Ratio	1.39	1.31	1.34	1.07	1.00	1.20
EV/EBITDA Ratio	8.66	8.13	9.45	11.55	9.42	10.31
EV/EBIT Ratio	10.89	10.22	12.46	18.27	13.68	14.48
EV/FCF Ratio	214.36	201.12	41.36	23.54	-	-

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 18, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Debt / Equity Ratio	2.06	2.06	2.70	2.07	1.82	1.79
Debt / EBITDA Ratio	3.06	3.06	3.92	5.01	4.46	3.89
Debt / FCF Ratio	80.65	80.65	18.43	11.45	-	-
Net Debt / Equity Ratio	1.85	1.85	2.42	1.57	1.49	1.42
Net Debt / EBITDA Ratio	2.91	2.91	3.78	4.27	4.02	3.38
Net Debt / FCF Ratio	72.13	72.13	16.55	8.69	-10.90	-68.92
Asset Turnover	1.06	1.06	1.11	1.04	1.03	1.06
Inventory Turnover	2.07	2.07	2.50	2.59	2.53	2.76
Quick Ratio	1.02	1.02	1.04	1.46	1.47	1.39
Current Ratio	2.96	2.96	2.76	2.94	3.33	2.97
Return on Equity (ROE)	29.72%	29.72%	17.80%	0.90%	11.97%	19.63%
Return on Assets (ROA)	8.48%	8.48%	7.41%	3.82%	4.72%	5.53%
Return on Invested Capital (ROIC)	13.00%	13.59%	12.04%	1.94%	6.49%	8.81%
Return on Capital Employed (ROCE)	16.40%	16.40%	13.00%	7.70%	9.00%	10.60%

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 18, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Earnings Yield	7.11%	7.83%	4.66%	0.36%	5.88%	6.35%
FCF Yield	0.70%	0.78%	4.04%	6.83%	-6.93%	-0.70%
Dividend Yield	1.39%	1.53%	1.91%	2.97%	3.77%	2.79%
Payout Ratio	19.75%	19.52%	40.30%	804.72%	59.63%	39.54%
Buyback Yield / Dilution	-0.70%	-0.70%	-0.38%	-0.05%	-	-0.08%
Total Shareholder Return	0.69%	0.83%	1.53%	2.92%	3.77%	2.72%

SEC Filings: 10-K · 10-Q